The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients

454 indexed citations

Abstract

loading...

About

This paper, published in 2013, received 454 indexed citations. Written by Ian Roberts, Tim Coats, Beverley J. Hunt, Eni Balogun, L. Barnetson, L. Caitlin Cook, Taemi Kawahara, Pablo Perel, David Prieto‐Merino and M Ramos covering the research area of Biochemistry, Critical Care and Intensive Care Medicine and Emergency Medicine. It is primarily cited by scholars working on Critical Care and Intensive Care Medicine (230 citations), Emergency Medicine (195 citations) and Biochemistry (177 citations). Published in Health Technology Assessment.

In The Last Decade

doi.org/10.3310/hta17100 →

Countries where authors are citing The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients

Specialization
Citations

This map shows the geographic impact of The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients more than expected).

Fields of papers citing The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.3310/hta17100.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026